Pidilizumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pidilizumab, covering 2018-03-19 to 2018-03-19. Get the full timeline:
Most recent: Clinical Trial Update: Pidilizumab in Treating Patients With Stage III-IV Diffuse Large B-Cell Lymphoma Following First Remission [Phase 2]